THURSDAY, Sept. 11, 2024 -- Two monoclonal antibody treatments to slow Alzheimer's disease, lecanemab (Leqembi) and donanemab (Kisunla), have been...
Vous n'êtes pas connecté
Britain's drug regulator authorized the Alzheimer's drug Leqembi on Thursday, saying it's the first medicine to show some impact in slowing the progression of the neurodegenerative disease.
THURSDAY, Sept. 11, 2024 -- Two monoclonal antibody treatments to slow Alzheimer's disease, lecanemab (Leqembi) and donanemab (Kisunla), have been...
Life in the United States has changed drastically in the last several decades. Technology, pharmaceutical and medical interventions, dietary shifts,...
Many speakers during public comment opposed the rate hike, with some saying they couldn't afford both utility bills and medicine.
Alzheimer’s disease is one of the leading causes of memory loss and confusion in older people worldwide. It is also the most common type of brain...
Former ECB head gives his diagnosis but European Union likely won’t agree to take its medicine
Donald Trump seems to have adopted a strategy whose name was coined by former British Prime Minister Boris Johnson, according to a new analysis.The...
Researchers at Wake Forest University School of Medicine have made an important discovery that connects high sugar intake to Alzheimer’s disease, a...
'Britain's misguided decision will only embolden Hamas," Netanyahu said. The U.K.'s Chief Rabbi condemned the partial arms suspension as 'beggars...
'Britain's misguided decision will only embolden Hamas," Netanyahu said. The U.K.'s Chief Rabbi condemned the partial arms suspension as 'beggars...
by Kavitha SuranaProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one...